Associate Professor, Internal Medicine

Department of Microbiology
Lab: 412 Biological Sciences Building
Office: 476 Biological Sciences Building
484 W. 12th Avenue
Columbus, OH 43210
Phone: 614-292-3256
Fax: 614-292-8120

Research Focus

Dr. Kwiek is molecular pharmacologist and virologist whose PhD focused on the mechanism of action of antimalarial therapeutics. During his post-doctoral fellowship, he studied retrovirology and molecular epidemiology. His independent research program uses the tools of molecular virology, evolutionary biology, and molecular pharmacology to understand HIV-1 replication and pathogenesis. Specifically, he has combined molecular virology and epidemiology to determine the contribution of maternal-fetal blood admixture and syphilis co-infection to in utero and intrapartum HIV transmission; used single genome amplification to isolate HIV-1c from blood and placenta to identify regions of HIV-1 envelope and LTR associated with HIV-1 transmission and replication; defined the HIV-1 reactivation properties of a novel HDAC inhibitor (AR-42); discovered a novel fatty acid synthase inhibitor which has both anti-cancer (Alwarawrah et al.) and anti-HIV (submitted) activity; characterized human breast milk purchased on the internet. 


Post-Doctoral Training: Department of Epidemiology, University of North Carolina at Chapel Hill, 2002-2007
PhD: University of Virginia, 2003
BS: University of Rochester, 1995

Kwiek Lab  ORCID